ONCOLOGY: ATAC Trial: Anastrozole Still Superior At Over Eight Years’ Follow Up

Audio Journal of Oncology, December 15th, 2007 Reporting from: San Antonio Breast Cancer Symposium, 13-16 December, 2007 ATAC Trial: Anastrozole Still Superior At Over Eight Years’ Follow Up JACK CUZICK, Wolfson Institute of Preventive Medicine, London REFERENCE: ABSTRACTS 41, 2069, 2071 New data from the ATAC trial, which is testing anastrozole and tamoxifen in early breast cancer, have demonstrated the continued superiority of the aromatase inhibitor. Among other things, the data now show a benefit in the time to distant recurrence. Derek Thorne heard more from Jack Cuzick, of the Wolfson Institute of Preventive Medicine in London.

You can listen to ONCOLOGY: ATAC Trial: Anastrozole Still Superior At Over Eight Years’ Follow Up online on Radio and Podcast. Open the player on this page to stream the available audio.

ONCOLOGY: ATAC Trial: Anastrozole Still Superior At Over Eight Years’ Follow Up is an episode from Audio Medica News - Medical News Interviews by Audio Medica.

This episode is 00:06:36 long.

This episode was published on Dec 15, 2007.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Audio Medica News - Medical News Interviews when more episodes are available from the podcast feed.